249 related articles for article (PubMed ID: 35763348)
1. Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection.
Semmes EC; Miller IG; Wimberly CE; Phan CT; Jenks JA; Harnois MJ; Berendam SJ; Webster H; Hurst JH; Kurtzberg J; Fouda GG; Walsh KM; Permar SR
J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35763348
[TBL] [Abstract][Full Text] [Related]
2. ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission.
Semmes EC; Miller IG; Rodgers N; Phan CT; Hurst JH; Walsh KM; Stanton RJ; Pollara J; Permar SR
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427588
[TBL] [Abstract][Full Text] [Related]
3. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.
Semmes EC; Miller IG; Rodgers N; Phan CT; Hurst JH; Walsh KM; Stanton RJ; Pollara J; Permar SR
medRxiv; 2023 Mar; ():. PubMed ID: 36993668
[TBL] [Abstract][Full Text] [Related]
4. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
Nelson CS; Huffman T; Jenks JA; Cisneros de la Rosa E; Xie G; Vandergrift N; Pass RF; Pollara J; Permar SR
Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6267-6272. PubMed ID: 29712861
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus.
Harnois MJ; Dennis M; Stöhr D; Valencia SM; Rodgers N; Semmes EC; Webster HS; Jenks JA; Barfield R; Pollara J; Chan C; Sinzger C; Permar SR
J Infect Dis; 2022 Nov; 226(9):1667-1677. PubMed ID: 35970817
[TBL] [Abstract][Full Text] [Related]
6. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity.
Jenks JA; Goodwin ML; Permar SR
Front Immunol; 2019; 10():2110. PubMed ID: 31555298
[TBL] [Abstract][Full Text] [Related]
8. Maternal immune correlates of protection against placental transmission of cytomegalovirus.
Itell HL; Nelson CS; Martinez DR; Permar SR
Placenta; 2017 Dec; 60 Suppl 1(Suppl 1):S73-S79. PubMed ID: 28456432
[TBL] [Abstract][Full Text] [Related]
9. Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
Webster H; Valencia S; Kumar A; Chan C; Dennis M; Roark H; Woods A; John S; Carfi A; Permar SR
Vaccine; 2021 Sep; 39(38):5358-5367. PubMed ID: 34393017
[TBL] [Abstract][Full Text] [Related]
10. Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.
Boppana SB; Britt WJ
Methods Mol Biol; 2021; 2244():403-463. PubMed ID: 33555597
[TBL] [Abstract][Full Text] [Related]
11. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
Permar SR; Schleiss MR; Plotkin SA
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
[TBL] [Abstract][Full Text] [Related]
12. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
14. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
Fu TM; An Z; Wang D
Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
[TBL] [Abstract][Full Text] [Related]
15. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
Plachter B
Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
Gerna G; Lilleri D
New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
[TBL] [Abstract][Full Text] [Related]
17. Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
Nelson CS; Vera Cruz D; Su M; Xie G; Vandergrift N; Pass RF; Forman M; Diener-West M; Koelle K; Arav-Boger R; Permar SR
J Virol; 2019 Mar; 93(5):. PubMed ID: 30518646
[TBL] [Abstract][Full Text] [Related]
18. Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development.
Hu X; Wang HY; Otero CE; Jenks JA; Permar SR
Annu Rev Virol; 2022 Sep; 9(1):491-520. PubMed ID: 35704747
[TBL] [Abstract][Full Text] [Related]
19. Development of novel vaccines against human cytomegalovirus.
Cui X; Snapper CM
Hum Vaccin Immunother; 2019; 15(11):2673-2683. PubMed ID: 31017831
[TBL] [Abstract][Full Text] [Related]
20. Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia.
Semmes EC; Li SH; Hurst JH; Yang Z; Niedzwiecki D; Fouda GG; Kurtzberg J; Walsh KM; Permar SR
Clin Infect Dis; 2022 Apr; 74(7):1131-1140. PubMed ID: 34260701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
